Brio: A European Prospective Observational Study to Assess the Burden of Disease and Treatment in Metastatic Breast Cancer (Mbc) Patients Treated with Oral Vinorelbine (Nvboral) or Intravenous Vinorelbine (Ivvino)

Abstract

A647 month after of the surgery we applied EORTC questionnaires QLQ-C30, PR25, and IN-PATSAT32. The scores for each questionnaire were calculated according formulas and instruction in the EORTC Scoring Manual. We calculated mean and standard deviation for each score. Results: Global Health Status/QoL has a mean score 74.80 (±20.74); the functional scales: physical 87.4 (±18.08); emotional 80.3 (±17.23); role 87.6 (±24.44), social 89.4 (±20.09). Symptoms scales: fatigue 15.6 (±15.48); insomnia, 27.3 (±30.00), pain 12 (±17.27), constipation 18.4 (±27.63), financial difficulties 17 (±29.38) the others symptom scales showed mean scores under 10. For scales in PR25 questionnaire, the scores were: sexual activity 72.7 (±20.68), sexual function 59.0 (±31.45); urinary symptoms 32.5 (±21.57), symptoms related with hormonal therapy 17.5 (±14.13), incontinence support 29.2 (±38.24). About scores for IN-PATSAT32, for doctors: Interpersonal skills 88.30 (±16.72); technical skills 87.23 (±19.95); capacity to bring information 89.01 (±17.29); availability 88.56 (±16.85); for nurse: interpersonal skills 87.41 (±16.74) technical skills 86.52 (±18.51); capacity to bring information 84.40 (±19.00); availability 79.26 (±20.89); other personnel kindness 80.85 (±20.47), access 76.86 (±23.16), waiting time 82.18 (±21.45), exchange of information 77.66 (±22.86), comfort/cleanness 80.85 (±21.62) and general satisfaction 84.57 (±18.46). ConClusions: The functional scales for QLQ-C30 showed a good quality of life, however symptom scales related to sexual function showed a diminished QoL, satisfaction with doctors and nurses is good, but not for other personnel.objeCtives: To determine HRQoL and patient satisfaction scores in prostate cancer patients treated through radical prostatectomy with a curative intent. Methods: Were selected prostate cancer patients treated through radical prostatectomy. One